Resveratrol in management of bone and spinal cancers
G Chen, H Xia, Z Zhang, H Yu - Natural product research, 2019 - Taylor & Francis
Bone cancer is a malignant primary tumour of the bone with different typing, such as,
osteosarcoma, chondrosarcoma, Ewing's sarcoma and fibrosarcoma. Despite the clinical …
osteosarcoma, chondrosarcoma, Ewing's sarcoma and fibrosarcoma. Despite the clinical …
[HTML][HTML] Resveratrol is cytotoxic and acts synergistically with NF-κB inhibition in osteosarcoma MG-63 cells
N Xu, L Wang, S Fu, B Jiang - Archives of medical science: AMS, 2021 - ncbi.nlm.nih.gov
Results Our data suggested that Res blocks cell proliferation, migration, and invasion, and
activates apoptotic cell death in osteosarcoma MG-63 cells. We found that Res potentially …
activates apoptotic cell death in osteosarcoma MG-63 cells. We found that Res potentially …
[HTML][HTML] Antitumor activity of resveratrol against human osteosarcoma cells: A key role of Cx43 and Wnt/β-catenin signaling pathway
D Xie, GZ Zheng, P Xie, QH Zhang, FX Lin, B Chang… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Osteosarcoma is a high-grade bone sarcoma with strong invasive ability. However,
treatment with traditional chemotherapeutic drugs is limited by low tolerability and side …
treatment with traditional chemotherapeutic drugs is limited by low tolerability and side …
Multiple effects of resveratrol on osteosarcoma cell lines
A De Luca, D Bellavia, L Raimondi, V Carina, V Costa… - Pharmaceuticals, 2022 - mdpi.com
Osteosarcoma (OS) is the most common primary bone sarcoma affecting the life of pediatric
patients. The clinical treatment faces numerous difficulties, including the adverse effects of …
patients. The clinical treatment faces numerous difficulties, including the adverse effects of …
Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation
Multiple myeloma is characterized by the accumulation of clonal malignant plasma cells in
the bone marrow, which stimulates bone destruction by osteoclasts and reduces bone …
the bone marrow, which stimulates bone destruction by osteoclasts and reduces bone …
A review of resveratrol as a potent chemoprotective and synergistic agent in cancer chemotherapy
Background: Cancer has become a major disease endangering human health around the
world. Conventional chemotherapy suffers from many side effects including pain …
world. Conventional chemotherapy suffers from many side effects including pain …
[HTML][HTML] Resveratrol for cancer therapy: Challenges and future perspectives
B Ren, MXY Kwah, C Liu, Z Ma, MK Shanmugam… - Cancer letters, 2021 - Elsevier
Abstract Resveratrol (3, 4', 5-trihydroxy-trans-stilbene) has been expected to ameliorate
cancer and foster breakthroughs in cancer therapy. Despite thousands of preclinical studies …
cancer and foster breakthroughs in cancer therapy. Despite thousands of preclinical studies …
Effects and mechanisms of resveratrol for prevention and management of cancers: An updated review
SX Wu, RG Xiong, SY Huang, DD Zhou… - Critical Reviews in …, 2023 - Taylor & Francis
Cancer is a severe public health problem. Resveratrol is a famous natural compound that
has various bioactivities, such as antioxidant, anti-inflammatory, antidiabetic and antiaging …
has various bioactivities, such as antioxidant, anti-inflammatory, antidiabetic and antiaging …
Resveratrol and its analogues: promising antitumor agents
HL Zhu - Anti-Cancer Agents in Medicinal Chemistry …, 2011 - ingentaconnect.com
Resveratrol, a well-know natural product and a major component in grape, has attracted
considerable attention as one of the most promising cancer during the past decade. Many …
considerable attention as one of the most promising cancer during the past decade. Many …
Resveratrol: potential as anticancer agent
JK Aluyen, QN Ton, T Tran, AE Yang… - Journal of dietary …, 2012 - Taylor & Francis
Background: Cancer is one of the leading causes of deaths in the world. Current
chemotherapeutic agents are associated with serious side effects in patients therefore …
chemotherapeutic agents are associated with serious side effects in patients therefore …